Walker Luke Nathaniel 4
4 · Harpoon Therapeutics, Inc. · Filed Jan 26, 2023
Insider Transaction Report
Form 4
Walker Luke Nathaniel
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-24+100,000→ 100,000 totalExercise: $0.89Exp: 2033-01-23→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the total stock option will vest and become exercisable every six months following the vesting commencement date of January 24, 2023, subject to the continuing employment of the Reporting Person on each vesting date.